SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-182808
Filing Date
2023-07-06
Accepted
2023-07-06 16:38:59
Documents
13
Period of Report
2023-06-29
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d816117d8k.htm   iXBRL 8-K 27466
2 EX-3.1 d816117dex31.htm EX-3.1 3842
  Complete submission text file 0001193125-23-182808.txt   159397

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA txmd-20230629.xsd EX-101.SCH 2871
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE txmd-20230629_lab.xml EX-101.LAB 18739
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE txmd-20230629_pre.xml EX-101.PRE 11721
7 EXTRACTED XBRL INSTANCE DOCUMENT d816117d8k_htm.xml XML 3554
Mailing Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431
Business Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431 561-961-1900
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

IRS No.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-00100 | Film No.: 231074110
SIC: 2834 Pharmaceutical Preparations